. Author manuscript; available in PMC: 2020 Jul 18.

Published in final edited form as: Cephalalgia. 2020 Mar 12;40(8):818–827. doi: 10.1177/0333102420911461

Table 3.

Influence of time to relief on responder rates stratified by treatment group.

Threshold for time to remission	All patients		Dexamethasone		Ketorolac		Naratriptan		Nerve block
Threshold for time to remission	Responders	Non-responders	Responders	Non-responders	Responders	Non-responders	Responders	Non-responders	Responders	Non-responders

2 hours	1 (1.7%)	59 (98.3%)	0 (0.0%)	13 (100%)	0 (0.0%)	9 (100%)	0 (0.0%)	9 (100%)	1 (3.4%)	28 (96.6%)
12 hours	4 (6.7%)	55 (93.3%)	0 (0.0%)	13 (100%)	0 (0.0%)	9 (100%)	0 (0.0%)	9 (100%)	4 (13.8%)	25 (86.2%)
24 hours	13 (21.7%)	47 (78.3%)	4 (30.8%)	9 (69.2%)	1 (11.1%)	8 (88.9%)	1 (11.1%)	8 (88.9%)	7 (24.1%)	22 (75.9%)
48 hours	21 (35.0%)	39 (64.0%)	5 (38.5%)	8(71.5%)	4 (44.4%)	5 (55.6%)	2 (22.2%)	7 (77.8%)	10 (34.5%)	19 (65.5%)
72 hours	24 (41.0%)	35 (59.0%)	6 (46.2%)	7 (53.8%)	5 (55.6%)	4 (44.4%)	2 (22.2%)	7 (77.8%)	12 (41.4%)	17 (58.6%)
96 hours	30 (50.0%)	30 (50.0%)	6 (46.2%)	7 (53.8%)	5 (55.6%)	4 (44.4%)	5 (55.6%)	4 (44.4%)	14 (48.3%)	15 (51.7%)